Recent Articles By The Author
Rite Aid Takes a Beating After Report of Walgreens Deal Fears
Rite Aid shares fell in dramatic fashion on Friday.
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
New bowel drug Trulance will be available for patients later this quarter.
EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks
The autoinjector will be free for insured patients and those whose annual income is less than $100,000.
GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open
Here's how biotech and healthcare stocks are moving ahead of market's open.
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.